Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Feb 6, 2019; 7(3): 260-269
Published online Feb 6, 2019. doi: 10.12998/wjcc.v7.i3.260

Table 1 Patient and cancer characteristics

Characteristics	n (%)
mean age	64.7 yr (range 38–92 yr)¹
Male sex	80%¹
Stage
Stage I–IIA	11 (11.8)
Stage IIB–III	56 (60.2)
Stage IVA–IVB	21 (22.6)
Unknown	5 (5.4)
Grade
Grade I	11 (11.8 )
Grade II	32 (34.4 )
Grade III	44 (47.3)
Unknown	6 (6.5 )
Radical surgery	38 (40.9)
Definitive oncological treatment	5 (5.4)
Palliative treatment	50 (53.7)
Cause of death²
Esophageal carcinoma	59 (85.5)
Myocardial infarction	2 (2.9)
Pneumonia	2 (2.9)
Other type of carcinoma	1 (1.4)
Pulmonary embolism	1 (1.4)
Cerebral infarction	1 (1.4)
Unknown	2 (2.9)

¹80 patients with data available.

²69 patients died during follow-up.

Citation: Söderström HK, Kauppi JT, Oksala N, Paavonen T, Krogerus L, Räsänen J, Rantanen T. Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma. World J Clin Cases 2019; 7(3): 260-269
URL: https://www.wjgnet.com/2307-8960/full/v7/i3/260.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i3.260

Söderström HK, Kauppi JT, Oksala N, Paavonen T, Krogerus L, Räsänen J, Rantanen T. Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma. World J Clin Cases 2019; 7(3): 260-269 [PMID: 30746368 DOI: 10.12998/wjcc.v7.i3.260]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.